Pharmacokinetics and Safety of Ceftazidime-Avibactam in Neonates and Young Infants: a Phase 2a, Multicenter Prospective Trial
{{output}}
Background: This phase 2a study evaluated pharmacokinetics and safety of ceftazidime-avibactam (CAZ/AVI; combination dosed as fixed 4:1 ratio) in neonates and young infants with suspected/confirmed infections due to Gram-negative... ...
